Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Wei Huang
Brain Surgery in Combination With Tyrosine Kinase Inhibitor and Whole Brain Radiotherapy for Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer With Brain Metastases
Scientific Reports
Multidisciplinary
Related publications
Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
P1.01-36 Thoracic Surgery in Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases
Anticancer Research
Medicine
Cancer Research
Oncology
Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Meta-Analysis
PLoS ONE
Multidisciplinary
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer
Current Gerontology and Geriatrics Research
Gerontology
Geriatrics
Quick Regression of Brain Metastases From Lung Adenocarcinoma With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Case Report and Literature Review
Molecular and Clinical Oncology
Cancer Research
Oncology
Clinical Studies on Conformal Radiotherapy Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Second-Line Treatment of Non-Small Cell Lung Cancer
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study
Biomedical Journal
Medicine
The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
